Your browser doesn't support javascript.
loading
Can circulating PD-1, PD-L1, BTN3A1, pan-BTN3As, BTN2A1 and BTLA levels enhance prognostic power of CA125 in patients with advanced high-grade serous ovarian cancer?
Fanale, Daniele; Corsini, Lidia Rita; Brando, Chiara; Cutaia, Sofia; Di Donna, Mariano Catello; Filorizzo, Clarissa; Lisanti, Maria Chiara; Randazzo, Ugo; Magrin, Luigi; Romano, Raffaella; Bazan Russo, Tancredi Didier; Olive, Daniel; Vieni, Salvatore; Pantuso, Gianni; Chiantera, Vito; Russo, Antonio; Bazan, Viviana; Iovanna, Juan Lucio.
Afiliación
  • Fanale D; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Corsini LR; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Brando C; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Cutaia S; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Di Donna MC; Department of Gynecologic Oncology, University of Palermo, Palermo, Italy.
  • Filorizzo C; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Lisanti MC; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Randazzo U; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Magrin L; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Romano R; Department of Gynecologic Oncology, University of Palermo, Palermo, Italy.
  • Bazan Russo TD; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Olive D; Team Immunity and Cancer, Centre de Recherche en Cancérologie de Marseille (CRCM), Institut National de la Santé et de la Recherche Médicale (INSERM) U1068, Centre National de la Recherche Scientifique Unité Mixte de Recherche (CNRS UMR) 7258 Aix-Marseille Université and Institut Paoli-Calmettes, Ma
  • Vieni S; Division of General and Oncological Surgery, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Pantuso G; Division of General and Oncological Surgery, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Chiantera V; Department of Gynecologic Oncology, University of Palermo, Palermo, Italy.
  • Russo A; Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo, Italy.
  • Bazan V; Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, Palermo, Italy.
  • Iovanna JL; Centre de Recherche en Cancérologie de Marseille (CRCM), Institut National de la Santé et de la Recherche Médicale (INSERM) U1068, Centre National de la Recherche Scientifique Unité Mixte de Recherche (CNRS UMR) 7258, Aix-Marseille Université and Institut Paoli-Calmettes, Parc Scientifique et Techno
Front Oncol ; 12: 946319, 2022.
Article en En | MEDLINE | ID: mdl-36212445
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Italia